Background: Cancer is an extremely heterogeneous disease, both intra and inter cancer types.

While studies have established the existence of differences in the epidemiological and clinical patterns of lung adenocarcinoma between male and female patients, we know relatively little regarding the molecular mechanisms underlying such sex-based differences.